Literature DB >> 4333399

1,25-dihydroxycholecalciferol: a potent stimulator of bone resorption in tissue culture.

L G Raisz, C L Trummel, M F Holick, H F DeLuca.   

Abstract

1,25-Dihydroxycholecalciferol (DHCC), isolated from kidney homogenates incubated with 25-hydroxycholecalciferol (HCC), stimulated the release of previously incorporated (45)45Ca from fetal rat bones in organ culture, at concentrations of 10(-10) to 10(-8)M. The dose response curves for 1,25-DHCC and 25-HCC, the parent compound, are parallel, but 1,25-DHCC is about 100 times as potent on a weight basis. Brief exposure to maximum doses of either agent leads to prolonged bone resorption.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4333399     DOI: 10.1126/science.175.4023.768

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  128 in total

1.  Contrasting effects on bone formation and on fracture healing of cholecalciferol and of 1 alpha-hydroxycholecalciferol.

Authors:  S Dekel; A Ornoy; E Sekeles; D Noff; S Edelstein
Journal:  Calcif Tissue Int       Date:  1979-11-06       Impact factor: 4.333

2.  The biological activity of synthetic 25,26-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol in vitamin D-deficient rats.

Authors:  L Miravet; J Redel; M Carre; M L Queillé; P Bordier
Journal:  Calcif Tissue Res       Date:  1976-12-02

3.  Lack of in vitro evidence for storage of 1,25-dihydroxycholecalciferol (1,25(OH)2D3) and 1,25(OH)2D3 binding protein in skeletal matrix.

Authors:  S Boonen; J Aerssens; I Jans; E Van Herck; I Vandewal; J Peeters; R Van den Eynde; J Dequeker; R Bouillon
Journal:  Calcif Tissue Int       Date:  1996-12       Impact factor: 4.333

Review 4.  1,25-Dihydroxyvitamin D-related hypercalcemia in lymphoma: two case reports.

Authors:  J P Devogelaer; M Lambert; B Boland; C Godfraind; H Noel; C Nagant de Deuxchaisnes
Journal:  Clin Rheumatol       Date:  1990-09       Impact factor: 2.980

5.  Metabolism of 1,25-dihydroxycholecalciferol in the rat.

Authors:  C A Frolik; H F DeLuca
Journal:  J Clin Invest       Date:  1972-11       Impact factor: 14.808

6.  24,25(OH)2D3, bone formation, and bone resorption in vitamin D-deficient, azotemic rats.

Authors:  W G Goodman; D J Baylink; D J Sherrard
Journal:  Calcif Tissue Int       Date:  1984-03       Impact factor: 4.333

7.  Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis.

Authors:  N H Bell; P H Stern; E Pantzer; T K Sinha; H F DeLuca
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

8.  1 alpha,25-dihydroxyvitamin D3 promotes fusion of mouse alveolar macrophages both by a direct mechanism and by a spleen cell-mediated indirect mechanism.

Authors:  E Abe; C Miyaura; H Tanaka; Y Shiina; T Kuribayashi; S Suda; Y Nishii; H F DeLuca; T Suda
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

9.  1,25-Dihydroxyvitamin D3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption.

Authors:  P M McSheehy; T J Chambers
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

10.  Partial purification of osteoclast-activating factor from phytohemagglutinin-stimulated human leukocytes.

Authors:  R A Luben; G R Mundy; C L Trummel; L G Raisz
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.